Welcome to our dedicated page for Nugene Intl news (Ticker: NUGN), a resource for investors and traders seeking the latest updates and insights on Nugene Intl stock.
Nugene International Inc (NUGN) drives innovation in customized skincare and therapeutic dermatology solutions from its Irvine, CA headquarters. This news hub provides investors and industry professionals with essential updates on the company’s product developments, regulatory milestones, and strategic partnerships.
Access authoritative reports on NUGN’s core activities including new product formulations, clinical trial progress for its topical burn treatment, and distribution network expansions. The curated collection features earnings announcements, research breakthroughs, and executive leadership updates critical for understanding the company’s market position.
All content undergoes rigorous verification to ensure accuracy and relevance for stakeholders. Regular updates maintain alignment with evolving industry regulations and consumer trends in personalized skincare solutions.
Bookmark this page for streamlined access to NUGN’s latest developments in cosmetic science and therapeutic dermatology. Combine this resource with SEC filings and market analysis tools for comprehensive investment research.
NuGene International, Inc./Livento Group, Inc. (OTC Pink: NUGN) has initiated the Public Offering process for its logistics project, EuroDot. With final stages underway, legal and financial documents are being prepared for a Reg A listing on OTC Markets. Livento Group aims to attract U.S. investors for future acquisitions, targeting revenues of $50 million by 2024 from two profitable acquisition targets, one with $14 million and another with $20 million in revenues, respectively. Initial share price for investors is set at $0.5. A detailed timeline and further financial disclosures are expected in the coming weeks.
NuGene International, Inc./Livento Group (OTC Pink: NUGN) has signed a binding Letter of Intent to acquire a Software Engineering Company specializing in AI and Robotics. The deal is expected to finalize in January 2023 and aims to enhance Livento's business portfolio. The target company is projected to generate $400,000 in revenue for 2023 with a 50% YOY increase. Additionally, Livento plans to leverage available EU grants of $750,000 to support the acquisition's growth. The acquisition is anticipated to provide positive cash flow from day one.
FAQ
What is the current stock price of Nugene Intl (NUGN)?
What is the market cap of Nugene Intl (NUGN)?
